Los puntos clave no están disponibles para este artículo en este momento.
In asymptomatic persons at average risk for colorectal cancer, multitarget stool DNA testing detected significantly more cancers than did FIT but had more false positive results. (Funded by Exact Sciences; ClinicalTrials.gov number, NCT01397747.).
Imperiale et al. (Wed,) studied this question.